Aberdeen Group’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.6M | Buy |
902,751
+142,936
| +19% | +$2M | 0.02% | 544 |
|
|
2025
Q1 | $10.3M | Buy |
759,815
+357,533
| +89% | +$4.86M | 0.02% | 559 |
|
|
2024
Q4 | $8.2M | Buy |
402,282
+38,603
| +11% | +$787K | 0.02% | 546 |
|
|
2024
Q3 | $10.6M | Sell |
363,679
-209,356
| -37% | -$6.1M | 0.02% | 511 |
|
|
2024
Q2 | $13.3M | Buy |
573,035
+57,016
| +11% | +$1.32M | 0.03% | 461 |
|
|
2024
Q1 | $10.6M | Buy |
516,019
+191,190
| +59% | +$3.92M | 0.02% | 539 |
|
|
2023
Q4 | $6.97M | Buy |
+324,829
| New | +$6.97M | 0.02% | 617 |
|